UCSF at #ASCO24
Each year UCSF Helen Diller Family Comprehensive Cancer Center members, physicians, faculty members, and advocates participate in the Annual Meeting of the American Society of Clinical Oncology (ASCO).
Cancer Center faculty presented a wealth of expertise in cancer research, prevention, and care at the 2024 ASCO Annual Meeting in Chicago. The theme of this yearʻs meeting was "The Art and Science of Cancer Care: From Comfort to Cure."
Conquer Cancer Awardees
Among the many HDFCCC-affiliated award winners were Drs. Kelsey Natsuhara, Lindsay Draper, Nashivai Kivuyo, and Christina Vallen Malichewe (pictured left to right). Global Cancer Program director Dr. Katherine Van Loon was on hand to applaud the recipients.
UCSF In the News
- ASCO 2024: Research May Inform Treatment of HER2-Low Breast Cancer
Pamela Munster, MD CancerTherapyAdvisor.com | June 20, 2024 - Exploring Genetic Counseling in Veterans with Advanced Prostate Cancer
Daniel Kwon, MD UroToday.com | June 13, 2024 - One Patient Changed This Oncologist's View of Hope. Here's How
Steve Pantilat, MD Medscape.com | June 12, 2024 - Guideline Update Seeks to Aid Clinicians in the Selection of Systemic Treatments for Advanced Hepatocellular Carcinoma
John Gordan, MD, PhD ASCO Post | June 10, 2024 - ASCO 2024: DeLLpro-300: Phase 1b Study of Tarlatamab in De Novo or Treatment-Emergent Neuroendocrine Prostate Cancer
Rahul Aggarwal, MD UroTodAY.COM | June 4, 2024 - Katherine C. Fuh, MD, PhD, on Ovarian Cancer: New Data on Batiraxcept and Paclitaxel
Katherine Fuh, MD ASCO Post | June 3, 2024 - Multicultural ASCO President-Elect Was Raised in Mexico by Parents Who Instilled a Sense of Duty to Make a Difference
Eric J. Small, MD, FASCO ASCO Post | June 3, 2024 - Advancing Targets: Latest FDA Approvals, Strategies in NSCLC Treatment Unveiled at ASCO 2024
Matt Gubens, MD, FASCO PharmacyTimes.com | June 2, 2024 - ASCO 2024: Development of a Machine Learning Model to Predict the Outcome of Randomized Clinical Trials of Patients with Metastatic Prostate Cancer
Ali Sabbagh, MD UroTodAY.COM | June 2, 2024 - UCSF Health Cancer Experts Featured at Premier Cancer Meeting
UCSF.edu | May 31, 2024
Honors and Awards
2025 ASCO President-elect: Eric Small, MD, FASCO
Newly Appointed ASCO Committee Leaders
- Amy Jo Chien, MD Chair-Elect, Annual Meeting Scientific Program Committee
- Sam Brondfield, MD, MA Chair-Elect, Education Council
- Niharika Dixit, MD. Chair-Elect, Health Policy Committee
Featured Voices #ASCO24
- Ana I. Velázquez Mañana, MD MS
Young Investigator Awards
- William S. Chen, MD
- Lindsey M. Draper, MD
- Kelsey Natsuhara, MD
- Michael P. Randall, MD
- Noah Younger, MD, PhD
International Development and Education Award in Palliative Care
- Christina Vallen Malichewe, MBChB, MMed, Muhimbili University of Health and Allied Sciences (Tanzania)
Global Oncology Young Investigator Award
- Nashivai Kivuyo, MD, MMed, Muhimbili University of Health and Allied Sciences (Tanzania)
Annual Meeting Merit Awards
- Kirkpatrick Fergus, MD
- Mulki Mehari,
- Ali Sabbagh, MD
Annual Meeting Research Awards
- Kevin Reyes, BS
Medical Student Rotation
- Kevin Reyes, BS
Oncology Summer Internships
- Asmaa Mahoui
- Alvine Ngouonga
- Maria Gonzalez
- Pearl Omo-sowho
- Diego Martinez Mendiola
- Austine Peng
- Mallory Shingle
- Isaac Avila-Vargas
Featured videos of presenters and attendees
- Kevin Reyes on presenting research and networking
- Daniel Kwon, MD on informed decision making for veterans
- Samantha Fisch, MD reports on metastatic breast cancer & leptomeningeal disease
- Ali Sabbagh, MD on machine learning
- Katherine Fuh, MD, PhD at educational session on gynecological cancers
- Steve Pantilat, FAAHPM, FACP, MHM on "Hope Beyond a Cure"
- Kevan Shokat, PhD on "The Story of KRAS-Directed Therapy From Bench to Bedside"
- Benjamin Joshua Lerman, MD, MS on ongitudinal tumor-wide sampling of glioblastoma
- Zoe Quandt, MD, MS on HLA associations with immunotherapy related endocrine toxicity
- Iona Cheng, MD, PhD on lung cancer risk in populations with no smoking history
Highlights on Twitter/X
Love sharing last night with our wonderful group of trainees & mentees, international collaborators, and @UCSFCancer faculty dedicated to mentoring the next gen of global leaders!
— Ana I. Velázquez Mañana, MD MSc (she/her/ella) (@AnaVManana) June 2, 2024
🙏🏽 @KVanLoonMD for co-hosting! #GlobalCancer #GlobalOnc #DEIA#ASCO24 @ASCO @rkmponce @BryanHLau… pic.twitter.com/0b8EamYAs1
Dr. @J_deGrootMD, Chief of Neuro-Oncology at @UCSF, Arm Co-PI of VAL-083 and GBM AGILE Arm Selection Committee Member presented results of the VAL-083 experimental arm of #GBMAGILE at #ASCO24
— Global Coalition for Adaptive Research (@GCAResearch) June 3, 2024
Key takeaways-
- GBM AGILE is a global adaptive platform trial designed to rapidly… pic.twitter.com/K6WTcTF4G4
I am thrilled that all four @UCSFCancer @UCSFDOM hematology/oncology fellows who applied for @ConquerCancerFd YIA awards received them.
— Krishna Komanduri, MD, FASTCT (@drkomanduri) May 30, 2024
Congrats @KelseyNatsuhara, @MikeRandallMD, @Lindsey__Draper and Noah Younger (and 💪🏽mentors) and Gerald Hsu, program director! 🎉 #ASCO24 👏🏽
🌟 Don’t miss stellar @UCSFIMChiefs @wustance poster #447 at #ASCO24 Care Delivery session studying under representation of Asian women in breast health research @ZSFGCare 👏🏼👏🏼👏🏼
— Kelsey Natsuhara (@KelseyNatsuhara) June 1, 2024
Mentored by @NiharikaDixit16 and 📸 starring Chief @DrTFriedlander #HealthEquity @UCSFCancer pic.twitter.com/EU71bpsFzn
Come by poster 432 to talk to @ardademirci14 about his work with @TravisZack2 applying large language models to identifying discrepancies in assigning performance status! #ai #asco24@UCSF_BCHSI @UCSFCancer @UCJointCPH pic.twitter.com/F2xOVPxToR
— Julian Hong (@julian_hong) June 1, 2024
Thanks for your commitment to a #meded international community of practice @s_brond and colleagues. Don't miss the excellent #asco24 Ed book article on pub med. @OncoAlert @UCSFCancer https://t.co/hlf9niJEhd
— Hope Rugo (@hoperugo) May 31, 2024
Caught our Deputy Director, Chief Scientific Officer, and 2025 president-elect of @ASCO Dr. Eric Small @ucsf after the #ASCO24 business meeting. Get to know him via this great bio in the @ASCOPost! https://t.co/NvvxdSiycg #UCSFProud pic.twitter.com/PxLDjln2vE
— UCSF Helen Diller Family Comprehensive Cancer Ctr (@UCSFCancer) June 3, 2024
📣 Check out the @UCSFCancer breast team at the poster session this morning #ASCO24 👏🏼👏🏼👏🏼
— Kelsey Natsuhara (@KelseyNatsuhara) June 2, 2024
🟢@laura_huppert #61 ADC sequencing
🟠@UCSFIMChiefs 🌟 resident Samantha Fisch #86 LMD outcomes
🔵Dr Jo Chien #193 ISPY EOP amcenestrant
🔴@hoperugo: #47 on elacestrant & #174 on saci pic.twitter.com/qvEGFZs1W8
Dr. Rahul Aggarwal @UCSFHospitals presenting “Phase 1b study of tarlatamab in de novo or treatment-emergent neuroendocrine prostate cancer (NEPC)” at #ASCO24 rapid oral abstract session #pcsm pic.twitter.com/eTnhk3oknK
— UCSF Helen Diller Family Comprehensive Cancer Ctr (@UCSFCancer) June 3, 2024
This was 💯 an #ASCO24 highlight for me. 🙏🏻 to @UngerKarla @Betzabe100 @NashiElias @BeckyJaneDB @geoffreybuckle (+👶🏼) for representing the Global Cancer Program @UCSFCancer @IGHSatUCSF 🇹🇿🇲🇽
— Katherine Van Loon, MD, MPH (@KVanLoonMD) June 4, 2024
Inspired for the future by @UCSF med students
Forever in awe of @AnaVManana🥂 https://t.co/tOpU5OT6XE
Still one of my favorite personal paper titles: What the blood knows. 2016.
— Aaron Logan, MD, PhD, MPhil (@hemedoc) June 3, 2024
[Coauthor Melanie Majure (then a fellow, now @UCSF breast cancer faculty) not on Twitter/X.] #ASCO24 #MRD https://t.co/w1fwjOwk9m
Convergent evolution of innate immune-modulating effectors in invasive fungal pathogens - check out this review by @UCSF @hitenmadhani & Michael J. Boucher in @Trends_Microbiol #ASCO24 https://t.co/4lC8esHm2M
— Cell Press (@CellPressNews) June 1, 2024